TY - JOUR
T1 - Hemodynamics, anatomy, and outcomes of quadricuspid aortic valves
T2 - Multimodality imaging assessment
AU - Zhang, Jingnan
AU - Li, Yihang
AU - Fang, Fang
AU - Wan, Junyi
AU - Xia, Zhiyuan
AU - Han, Yu
AU - Jiang, Shiliang
AU - Lv, Bin
AU - Zhi, Aihua
AU - Tse, Gary
AU - Chan, Jeffrey Shi Kai
AU - Zhang, Shaoxiong
AU - Pan, Xiangbin
AU - Zhang, Gejun
N1 - Publisher Copyright:
© 2024 Society of Cardiovascular Computed Tomography
PY - 2024/3/1
Y1 - 2024/3/1
N2 - Background: Quadricuspid aortic valve (QAV) is a rare congenital heart disease with a limited body of literature. This retrospective cohort study investigates QAV morphology, function, and clinical outcomes. Methods: Echocardiography was used to assess valvular function. Morphological characteristics such as phenotypes, raphe, regurgitant orifice area (ROA), and aortic dilation (diameter >40 mm) were assessed by cardiac CT. Patients were followed up for the combined event of all-cause death and aortic valve replacement (AVR). Results: Ninety QAV patients (screened from 322385 CT scans) were included (mean age 55.2 ± 13.6 years, 61.1 % male). Isolated significant aortic regurgitation (AR) was present in 75.6 % of patients. The cohort was dominated by type I (four equal leaflets, 37.8 %) and type II (3 larger and 1 smaller leaflets, 42.2 %) QAV. Fused raphe was present in 26.7 % of patients. ROACT was correlated with AR severity and aortic dilation (41.1 %, n = 37). Among patients without AVR at baseline (n = 60), one died and 17 underwent AVR during a median follow-up of 35.0 months (IQR:17.3–62.8). ROACT was associated with an increasing risk of combined event (as a categorical variable with a cut-off of 21.4 mm2, HR = 4.25, 95%CI 1.49–12.17, p = 0.007; as a continuous variable (per mm2 increment), HR = 1.04, 95%CI 1.01–1.07, p = 0.003). Additionally, ROACT had incremental prognostic value when added to the AR severity model (area under the receiver-operating characteristic curve increased from 86.8 to 88.4, p = 0.004). Conclusion: QAV is characterized by variable anatomy, progressive AR, concomitant cusp fusion and aortic enlargement. ROACT may be a potential ancillary prognostic marker in patients with QAV.
AB - Background: Quadricuspid aortic valve (QAV) is a rare congenital heart disease with a limited body of literature. This retrospective cohort study investigates QAV morphology, function, and clinical outcomes. Methods: Echocardiography was used to assess valvular function. Morphological characteristics such as phenotypes, raphe, regurgitant orifice area (ROA), and aortic dilation (diameter >40 mm) were assessed by cardiac CT. Patients were followed up for the combined event of all-cause death and aortic valve replacement (AVR). Results: Ninety QAV patients (screened from 322385 CT scans) were included (mean age 55.2 ± 13.6 years, 61.1 % male). Isolated significant aortic regurgitation (AR) was present in 75.6 % of patients. The cohort was dominated by type I (four equal leaflets, 37.8 %) and type II (3 larger and 1 smaller leaflets, 42.2 %) QAV. Fused raphe was present in 26.7 % of patients. ROACT was correlated with AR severity and aortic dilation (41.1 %, n = 37). Among patients without AVR at baseline (n = 60), one died and 17 underwent AVR during a median follow-up of 35.0 months (IQR:17.3–62.8). ROACT was associated with an increasing risk of combined event (as a categorical variable with a cut-off of 21.4 mm2, HR = 4.25, 95%CI 1.49–12.17, p = 0.007; as a continuous variable (per mm2 increment), HR = 1.04, 95%CI 1.01–1.07, p = 0.003). Additionally, ROACT had incremental prognostic value when added to the AR severity model (area under the receiver-operating characteristic curve increased from 86.8 to 88.4, p = 0.004). Conclusion: QAV is characterized by variable anatomy, progressive AR, concomitant cusp fusion and aortic enlargement. ROACT may be a potential ancillary prognostic marker in patients with QAV.
KW - Aortic dilation
KW - Aortic regurgitation
KW - Multimodality imaging assessment
KW - Quadricuspid aortic valve
UR - http://www.scopus.com/inward/record.url?scp=85185165210&partnerID=8YFLogxK
U2 - 10.1016/j.jcct.2024.01.008
DO - 10.1016/j.jcct.2024.01.008
M3 - Article
C2 - 38262851
AN - SCOPUS:85185165210
SN - 1934-5925
VL - 18
SP - 179
EP - 186
JO - Journal of Cardiovascular Computed Tomography
JF - Journal of Cardiovascular Computed Tomography
IS - 2
ER -